Vena, the only AI-powered planning platform built for the Microsoft technology ecosystem, today announced the general availability of six new pre-built, secure data connectors via Microsoft Fabric.

Microsoft will process M365 Copilot prompts and responses locally in 15 countries as part of its growing commitment to ...

Dubai, UAE – October 14, 2025 – Microsoft today announced a strategic investment to enable local data processing for Microsoft 365 Copilot in the United Arab Emirates, exclusively for qualified UAE ...

UAE operator Khazna Data Centers is expanding its footprint. The company this week announced plans to expand operational capacity by more than 1GW over the next five years across the Middle East and ...

U.S. medical imaging provider SimonMed Imaging is notifying more than 1.2 million individuals of a data breach that exposed their sensitive information. SimonMed Imaging is an outpatient medical ...

The Information Commissioner’s Office (ICO) in the UK has fined Capita, a provider of data-driven business process services, £14 million ($18.7 million) for a data breach incident in 2023 that exposed ...

Chat-GPT maker OpenAI is exploring the possibility of developing a data center in Argentina, in what would be its first facility in Latin America. The Argentine government this week announced the ...

Microsoft today announced a strategic investment to enable local data processing for Microsoft 365 Copilot in the UAE, exclusively for qualified UAE organisations. This milestone reinforces ...

DUBAI, 14th October, 2025 (WAM) -- Microsoft today announced a strategic investment to enable local data processing for Microsoft 365 Copilot in the UAE, exclusively for qualified UAE organisations.

ARMONK, N.Y. - IBM (NYSE:IBM), a prominent player in the IT Services industry with a market capitalization of $257 billion and annual revenue of $64 billion, announced today it has signed a definitive ...

Investing.com -- Tvardi Therapeutics (NASDAQ:TVRD) stock plunged 30% after the company reported disappointing preliminary data from its Phase 2 REVERT trial evaluating TTI-101 in idiopathic pulmonary ...